Non-Hormonal Birth Control Market
Number of pages: 100 | Report Format: PDF | Published date: May 05, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023-2031
|
Report Attribute |
Details |
|
Market Size Value in 2022 |
US$ 27.68 billion |
|
Revenue Forecast in 2031 |
US$ 52.19 billion |
|
CAGR |
7.3% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Type, Gender, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the global non-hormonal birth control market was valued at US$ 27.68 billion in 2022 and is expected to register a revenue CAGR of 7.3% to reach US$ 52.19 billion by 2031.
Non-hormonal Birth Control Market Fundamentals
Non-hormonal birth control methods have been in use for many years and are a popular option for individuals looking to avoid hormonal contraception. Condoms, diaphragms, cervical caps, and copper intrauterine devices (IUDs) are some examples of non-hormonal birth control devices. These birth control options work well at preventing conception and don't come with any negative side effects. Non-hormonal birth control has undergone several developments in recent years that have improved its efficacy and practicality. For instance, more effective and comfortable barrier techniques have been created recently, such as female condoms. Because of their ease of application and long-lasting effectiveness, copper IUDs have also gained popularity. Additionally, there has been an increase in research into techniques that promote fertility awareness, such as creating tools and apps that people can use to track their menstrual cycles and, more precisely, determine their fertile windows. These developments in non-hormonal contraception have given people more options to select from and improved their capacity to make educated decisions about their reproductive health.
This report is a crucial tool for the industry stakeholders to gather all the information about the market, customers, and competition. The report also provides the readers with valuable insights on the segmentation, regions, market size & forecast, revenue CAGRs, and other valuable data to help make informed strategic decisions. The study compiles information gathered from industry participants and specialists across the industry value chain. The report also taps into the qualitative and quantitative assessments by industry analysts. Our reports use different methods for estimating the market size and forecast, including secondary research, surveys and interviews, and statistical modeling. With these steps, our reports provide the most accurate market data. These datasets will cumulatively provide in-depth non-hormonal birth control market forecast to the industry stakeholders.
[123]
Non-hormonal birth control Market Dynamics
The non-hormonal birth control demand is increasing among women concerned about the adverse effects of hormonal contraception, which is one of the factors driving the expansion of the non-hormonal birth control industry. Many people are also looking for birth control options that are more natural or holistic and do not use artificial hormones. Additionally, non-hormonal birth control options have received more attention and education, encouraging more people to investigate them. The growing interest in non-hormonal birth control is also a result of the appeal of sustainable and eco-friendly lifestyles, as many of these practices are considered more environmentally benign. The development of this business has also been aided by improvements in non-hormonal birth control technologies and the availability of more practical and efficient solutions. Therefore, it is anticipated that the advantages associated with using non-hormonal birth control methods are the most important factors in improving the non-hormonal birth control dynamics in terms of the global non-hormonal birth control market forecast.
However, the lack of knowledge and instruction on non-hormonal birth control choices among medical professionals and patients is a major problem hindering the growth of non-hormonal birth control. Many people might not be aware of the range of non-hormonal birth control choices available to them and might not get enough guidance on the advantages and hazards of these techniques. Moreover, non-hormonal techniques also need to be used more carefully and consistently, which might be difficult for some people and might not be as effective as hormonal techniques. Further, access to hormone alternatives may be restricted in some places, especially in rural or low-income areas. It will be crucial to address these issues to guarantee that people have access to a full range of safe and reliable birth control choices.
Non-hormonal Birth Control Market Ecosystem
Non-hormonal Birth Control Market, by Type
Non-hormonal birth control Market, by Gender
Non-hormonal birth control Market by Type
[11111111111]
Based on the types, the non-hormonal birth control market is segmented into contraceptive devices and sterilization. The contraceptive devices are sub-segmented into condoms, diaphragms, cervical caps, sponges, vaginal rings, copper intra uterine devices (IUD), and other devices.
Contraceptive devices accounted for the largest revenue share of the global market in terms of the non-hormonal birth control market forecast. The segment dominated the market because they are more user-friendly and have higher effectiveness rates than other non-hormonal techniques, among other things. Once inserted, contraceptive methods like copper intrauterine devices (IUDs) and diaphragms effectively prevent pregnancy. These elements, along with ongoing research and development to enhance the functionality and aesthetics of contraceptive devices, are anticipated to fuel the non-hormonal birth control market's continued expansion.
Segmentation of the market refers to the division of the industry into subgroups based on factors such as type, gender, and region. Market segmentation data helps businesses to understand the preferences and unique needs of different customer groups and develop targeted sales strategies. This information also helps in identifying potential non-hormonal birth control market growth opportunities.
Non-hormonal Birth Control Market by Region
Based on the regions, the global non-hormonal birth control market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
According to the analysis of the non-hormonal birth control market overview, North America accounted for the largest revenue share of the global market. The high levels of education and awareness about birth control alternatives among medical professionals and patients in the area are thought to enhance the non-hormonal birth control market opportunity. Additionally, North America has a sizable market for non-hormonal birth control options, with many people choosing these methods out of personal preference or health considerations. Additionally, the region has robust birth control product regulations, which has aided in ensuring the security and effectiveness of non-hormonal options available on the market. The non-hormonal birth control market is likely to witness innovation due to continuing research and development activities in North America. New products and technologies are being created to satisfy customers' changing demands and preferences.
Based on the regions, the global non-hormonal birth control market is segmented into:
Regional demarcation of the industry will provide information on geographic pockets regarding the non-hormonal birth control market outlook, size, share, and growth rate. This data helps businesses evaluate the expansion potential into new regional markets, understand the competitive threats across different regions, and develop localized sales and expansion strategies.
Key Components of the Report
Non-hormonal birth Control Market Competitive Landscape
Multiple companies across the globe are investing in raising awareness and new product launches, which is expected to improve the non-hormonal birth control market outlook. Notable market participants account for the largest portion of the global non-hormonal birth control market size, include
The market competitive landscape is performed by collecting and analyzing information about the key competitors, the present industry trends, and market dynamics. It includes information collection and analysis on factors such as products, pricing, geographic outreach, customer demographics, marketing strategies, and recent developments. Competitive landscape assessment will help businesses identify the current prevalent or potential opportunities and threats, considering the non-hormonal birth control industry trends.
Non-hormonal birth control Market Strategic Development
Key Strengths of Our Report
Target Audience to Benefit from this Report.
Reasons to Buy this Report
Non-hormonal birth control refers to contraceptive methods that do not rely on hormones to prevent pregnancy.
The total global non-hormonal birth control market size in 2022 is US$ 27.68 billion.
North America will have the largest non-hormonal birth control market size during the forecast period from 2023 to 2031.
The global non-hormonal birth control market is expected to grow with a revenue CAGR of 7.3% during the forecast period from 2023 to 2031.
The resultant market size of the non-hormonal birth control market in 2031 will be US$ 52.19 billion.
Lack of knowledge among population and lower efficacy are the major challenge hampering the growth of the global non-hormonal birth control market.
The major strategies adopted by key market players involve strategic partnerships and collaborations to expand their market reach and capabilities
Increased need of proper birth control method without any adverse effect is the major driving factor necessitates the use of non-hormonal birth control.
Key players in the non-hormonal birth control market are CooperSurgical, Inc., Reckitt Benckiser Group plc, Mayer Laboratories, Inc., Bayer AG, Abbvie (Allergan), LifeStyles Healthcare Pte Ltd.
*Insights on financial performance are subject to the availability of information in the public domain